A study to evaluate clinical and metabolic profile in a type 1 diabetes cohort receiving Dpp-4 inhibitor plus Sglt2i compared to either drug alone as an adjuvant therapy …
169 A study to evaluate clinical and metabolic profile in a type 1 diabetes cohort receiving Dpp-4 inhibitor plus Sglt2 Page 1 Abstracts Indian Journal of Endocrinology and Metabolism ¦ …..... Read More